New Nonprofit Aims to Boost Funding for Longevity Science
A newly formed nonprofit called the Second Century Foundation is working to increase support for research that treats aging as a medical problem. It plans to fill funding gaps by preparing investor-oriented analyses, mapping how capital moves through the longevity field, and offering a simulation tool that compares targeting aging with treating individual age-related diseases. The foundation contends that slowing aging could produce much larger gains in healthy lifespan than curing single conditions such as cancer.
The Second Century Foundation is a tax-exempt private operating foundation launched to speed progress in treating aging as a medical condition. It says conventional funders often overlook work that neither yields academic papers nor promises a near-term investor exit, so it aims to support those gaps.
Its current efforts include an investor memo on longevity biotech exits, funding sources, and projected product value; a capital-flow map covering academic, industrial, and governmental sectors; and a no-cost, open-source simulator used in a browser that compares aging-focused medicine with treating individual age-related diseases. It also invites students to form clubs, projects, or startups.
The foundation’s push could influence how investors, researchers, and policymakers view aging research, potentially shifting some capital toward prevention-oriented longevity science. Patients and older adults may benefit if therapies emerge, but timelines and risks remain uncertain. Students and startups might find new collaboration pathways. Broader society could face questions about access, affordability, and prioritization if such treatments develop.